As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Oak Hill Wealth Advisors LLC, Simplex Trading LLC, IMC Chicago LLC, Curated Wealth Partners LLC, Private Capital Management LLC, Nomura Holdings Inc., Readystate Asset Management LP, HAP Trading LLC, BlueCrest Capital Management Ltd, Caas Capital Management LP, CMT Capital Markets Trading GmbH, Symmetry Peak Management LLC, Balyasny Asset Management L.P., Nomura Holdings Inc., Capital Fund Management S.A., PEAK6 Investments LLC, Eisler Capital UK Ltd., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Mendel Money Management, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, Jag Capital Management LLC, BNP Paribas Financial Markets, Gladius Capital Management LP, Concourse Financial Group Securities Inc., CTC LLC, National Bank of Canada FI, Simplex Trading LLC, XR Securities LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.